Summary:
We invite you to learn more about our clinical research trial to evaluate the safety and effectiveness of an investigational medication for moderate-to-severe plaque psoriasis. Your participation could play a vital role in advancing medical research.
Minimum eligibility requirements:
- 18 years of age or older.
- Diagnosed with moderate-to-severe plaque psoriasis at least 6 months ago.
- Candidate for phototherapy or systemic therapy
- Have not previously used apremilast (Otezla®).
Qualified Participants May Receive:
By participating, you may:
- Gain access to investigational medication at no cost.
- Contribute to the advancement of medicine and potentially more effective therapeutics.